The neurological complications of bariatric surgery

Archives of Neurology

Volumn 61, Issue 8, 2004, Pages 1185-1189

  Berger, Joseph R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTHRALGIA; ARTHRITIS; ATAXIA; BARIATRIC SURGERY; BEHAVIOR DISORDER; BRAIN DISEASE; BURNING FEET SYNDROME; CALORIC INTAKE; CANCER; CARDIOVASCULAR DISEASE; CARPAL TUNNEL SYNDROME; CAUSE OF DEATH; CLINICAL FEATURE; COMPARTMENT SYNDROME; COST OF ILLNESS; CRANIAL NERVE PARALYSIS; CYANOCOBALAMIN DEFICIENCY; DIABETES MELLITUS; ENERGY EXPENDITURE; FOLIC ACID DEFICIENCY; FOOD AVAILABILITY; HEALTH HAZARD; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOCALCEMIA; LUMBOSACRAL PLEXUS; LUNG DISEASE; MERALGIA PARESTHETICA; MONONEUROPATHY; MORNING STIFFNESS; MORTALITY; MUSCULOSKELETAL DISEASE; MYALGIA; MYOPATHY; MYOTONIA; NEUROLOGIC DISEASE; NICOTINIC ACID DEFICIENCY; OBESITY; OSTEOARTHRITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEIZURE; SPINAL CORD DISEASE; SYMPTOM; THIAMINE DEFICIENCY; VITAMIN D DEFICIENCY; WERNICKE ENCEPHALOPATHY;

GASTRIC BYPASS; HUMANS; NERVOUS SYSTEM DISEASES; OBESITY; POSTOPERATIVE COMPLICATIONS;

EID: 4043093578     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.8.1185     Document Type: Review

References (66)

1. Wilhelm C. Growing the market for anti-obesity drugs. Chem Market Rep. 2000;257:FR23-FR24.
2. Khan L, Serdula M, Bowman B, Williamson D. Use of prescription weight loss pills among U.S. adults in 1996-1998. Ann Intern Med. 2001;134:282-286.
3. Wellman NS, Friedberg B. Causes and consequences of adult obesity: health, social and economic impacts in the United States. Asia Pac J Clin Nutr. 2002;11 suppl 8:S705-S709.
4. Fisher BL, Schauer P. Medical and surgical options in the treatment of severe obesity. Am J Surg. 2002;184(suppl 2):9S-16S.
5. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79.
6. Allison D, Fontaine K, Manson J, Stevens J, Vanitallie T. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530-1538.
7. Lobstein TJ, James WP, Cole TJ. Increasing levels of excess weight among children in England. Int J Obes Relat Metab Disord. 2003;27:1136-1138.
8. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. Rockville, MD: National Heart, Lung, and Blood Institute: 1998.
9. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
10. Pope GD, Birkmeyer JD, Finlayson SR. National trends in utilization and in-hospital outcomes of bariatric surgery. J Gastrointest Surg. 2002;6:855-861.
11. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992;55(suppl 2): S615-S619.
12. Deitel M, Shikora SA. The development of the surgical treatment of morbid obesity. J Am Coll Nutr. 2002;21:365-371.
13. Livingston EH. Obesity and its surgical management. Am J Surg. 2002;184:103-113.
14. Azagra JS, Goergen M, Ansay J, et al. Laparoscopic gastric reduction surgery: preliminary results of a randomized, prospective trial of laparoscopic vs open vertical banded gastroplasty. Surg Endosc. 1999;13:555-558.
15. Higa KD, Boone KB, Ho T, Davies OG. Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg. 2000;135:1029-1034.
16. Schauer PR, lkramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515-529.
17. Pories W, MacDonald KG Jr, Morgan E, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992;55(suppl 2):582S-585S.
18. Yale C. Gastric surgery for morbid obesity: complications and long-term weight control. Arch Surg. 1989;124:941-946.
19. Fang J. The cost-effectiveness of bariatric surgery. Am J Gastroenterol. 2003;98:2097-2098.
20. Clegg A, Colquitt J, Sidhu M, Royle P, Walker A. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord. 2003;27:1167-1177.
21. Skroubis G, Sakellaropoulos G, Pouggouras K, Mead N, Nikiforidis G, Kalfarentzos F. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg. 2002;12:551-558.
22. Halverson JD. Metabolic risk of obesity surgery and long-term follow-up. Am J Clin Nutr. 1992;55(suppl 2):602S-605S.
23. Abarbanel JM, Berginer VM, Osimani A, Solomon H, Charuzi I. Neurologic complications after gastric restriction surgery for morbid obesity. Neurology. 1987;37:196-200.
24. Thaisetthawatkul P. Peripheral neuropathy following gastric bypass surgery. Paper presented at: 55th Annual Meeting of the American Academy of Neurology; Honolulu, Hawaii; March 29-April 5, 2003.
25. Ke ZJ, DeGiorgio LA, Volpe BT, Gibson GE. Reversal of thiamine deficiency-induced neurodegeneration. J Neuropathol Exp Neurol. 2003;62:195-207.
26. Caine D, Halliday G, Kril J, Harper C. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997;62:51-60.
27. Wernicke C. Lehrbuch der Gehirnkrankheiten fur Aerzte und Studirende. Kassel, Germany: Theodor Fischer; 1881:229-242.
28. Printen KJ, Mason EE. Gastric bypass for morbid obesity in patients more than fifty years of age. Surg Gynecol Obstet. 1977;144:192-194.
29. Ayub A, Faloon WW, Heinig RE. Encephalopathy following jejunoileostomy. JAMA. 1981;246:970-973.
30. Oczkowski WJ, Kertesz A. Wernicke's encephalopathy after gastroplasty for morbid obesity. Neurology. 1985;35:99-101.
31. Rothrock JF, Smith MS. Wernicke's disease complicating surgical therapy for morbid obesity. J Clin Neuroophthalmol. 1981;1:195-199.
32. MacLean JB. Wernicke's encephalopathy after gastric plication. JAMA. 1982;248:1311.
33. Haid RW, Gutmann L, Crosby TW. Wernicke-Korsakoff encephalopathy after gastric plication. JAMA. 1982;247:2566-2567.
34. Milius G, Rose S, Owen DR, Schenken JR. Probable acute thiamine deficiency secondary to gastric partition for morbid obesity. Nebr Med J. 1982;67:147-150.
35. Villar HV, Ranne RD. Neurologic deficit following gastric partitioning: possible role of thiamine. JPEN J Parenter Enteral Nutr 1984;8:575-578.
36. Bozbora A, Coskun H, Ozarmagan S, Erbil Y, Ozbey N, Orham Y. A rare complication of adjustable gastric banding: Wernicke's encephalopathy. Obes Surg. 2000;10:274-275.
37. Kramer LD, Locke GE. Wernicke's encephalopathy: complication of gastric plication. J Clin Gastroenterol. 1987;9:549-552.
38. Sola E, Morillas C, Garzon S, Ferrer JM, Martin J, Hernandez-Mijares A. Rapid onset of Wernicke's encephalopathy following gastric restrictive surgery. Obes Surg. 2003;13:661-662.
39. Gollobin C, Marcus WY. Bariatric beriberi. Obes Surg. 2002;12:309-311.
40. Chaves LC, Faintuch J, Kahwage S, Alencar Fde A. A cluster of polyneuropathy and Wernicke-Korsakoff syndrome in a bariatric unit. Obes Surg. 2002;12:328-334.
41. Koike H, Misu K, Hattori N, et al. Postgastrectomy polyneuropathy with thiamine deficiency. J Neurol Neurosurg Psychiatry. 2001;71:357-362.
42. Chang CG, Helling TS, Black WE, Rymer MM. Weakness after gastric bypass. Obes Surg. 2002;12:592-597.
43. Boni L, Kieckens L, Hendrikx A. An evaluation of a modified erythrocyte transketolase assay for assessing thiamine nutritional adequacy. J Nutr Sci Vitaminol (Tokyo). 1980;26:507-514.
44. Cirignotta F, Manconi M, Mondini S, Buzzi G, Ambrosetto P. Wernicke-Korsakoff encephalopathy and polyneuropathy after gastroplasty for morbid obesity: report of a case. Arch Neurol. 2000;57:1356-1359.
45. Toth C, Voll C. Wernicke's encephalopathy following gastroplasty for morbid obesity. Can J Neurol Sci. 2001;28:89-92.
46. Salas-Salvado J, Garcia-Lorda P, Cuatrecasas G, et al. Wernicke's syndrome after bariatric surgery. Clin Nutr. 2000;19:371-373.
47. Amaral JF, Thompson WR, Caldwell MD, Martin HF, Randall HT. Prospective hematologic evaluation of gastric exclusion surgery for morbid obesity. Ann Surg. 1985;201:186-193.
48. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991;70:229-245.
49. Williams J, Hall G, Thompson A, Cooke W. Neurological disease after partial gastrectomy. Br Med J. 1969;3:210-212.
50. Weir D, Gatenby P. Subacute combined degeneration of cord after partial gastrectomy. Br Med J. 1963;5366:1175-1176.
51. Brolin RE, Gorman JH, Gorman RO, et al. Are vitamin B12 and folate deficiency clinically important after roux-en-Y gastric bypass? J Gastrointest Surg. 1998;2:436-442.
52. Halverson J. Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg. 1986;52:594-598.
53. Brolin RE, Gorman RO, Milgrim LM, Kenler HA. Multivitamin prophylaxis in prevention of post-gastric bypass vitamin and mineral deficiencies. Int J Obes. 1991;15:661-667.
54. Lopez JF, Halimi S, Perillat Y. Pellagra-like erythema following vertical banded gastroplasty for morbid obesity [in French] Ann Chir. 2000;125:297-298.
55. Marinella MA. Ophthalmoplegia: an unusual manifestation of hypocalcemia. Am J Emerg Med. 1999;17:105-106.
56. Provenzale D, Reinhold RB, Golner B, et al. Evidence for diminished B12 absorption after gastric bypass: oral supplementation does not prevent low plasma B12 levels in bypass patients. J Am Coll Nutr. 1992;11:29-35.
57. Satya-Murti S, Howard L, Krohel G, Wolf B. The spectrum of neurologic disorder from vitamin E deficiency. Neurology. 1986;36:917-921.
58. Kumar N, McEvoy KM, Ahlskog JE. Myelopathy due to copper deficiency following gastrointestinal surgery. Arch Neurol. 2003;60:1782-1785.
59. Feit H, Glasberg M, Ireton C, Rosenberg RN, Thal E. Peripheral neuropathy and starvation after gastric partitioning for morbid obesity. Ann Intern Med. 1982;96:453-455.
60. Paulson GW, Martin EW, Mojzisik C, Carey LC. Neurologic complications of gastric partitioning. Arch Neurol. 1985;42:675-677.
61. Seehra H, MacDermott N, Lascelles RG, Taylor TV. Wernicke's encephalopathy after vertical banded gastroplasty for morbid obesity. BMJ. 1996;312:434.
62. Dahlquist NR, Perrault J, Callaway CW, Jones JD. D-Lactic acidosis and encephalopathy after jejunoileostomy: response to overfeeding and to fasting in humans. Mayo Clin Proc. 1984;59:141-145.
63. Stolberg L, Rolfe R, Gitlin N, et al. d-Lactic acidosis due to abnormal gut flora: diagnosis and treatment of two cases. N Engl J Med. 1982;306:1344-1348.
64. Gorecki PJ, Cottam D, Ger R, Angus LD, Shaftan GW. Lower extremity compartment syndrome following a laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2002;12:289-291.
65. Harwood SC, Chodoroff G, Ellenberg MR. Gastric partitioning complicated by peripheral neuropathy with lumbosacral plexopathy. Arch Phys Med Rehabil. 1987;68:310-312.
66. Ginsberg J, Quismorio FP Jr, DeWind LT, Mongan ES. Musculoskeletal symptoms after jejunoileal shunt surgery for intractable obesity: clinical and immunologic studies. Am J Med. 1979;67:443-448.